B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3 + regulatory T cells and protect against experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 188, Issue 4, 2012, Pages 1686-1697

  Sun, Jia Bin ^a   Czerkinsky, Cecil ^b   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLERA TOXIN B SUBUNIT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; LATENCY ASSOCIATED PEPTIDE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; OVA PEPTIDE; PEPTIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONJUGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; IMMUNIZATION; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHOLERA TOXIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLYCOPROTEINS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OVALBUMIN; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 84863174201     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101771     Document Type: Article

References (46)

1. + T cell immunity. Nat. Rev. Immunol. 10: 236-247.
2. Lampropoulou, V., E. Calderon-Gomez, T. Roch, P. Neves, P. Shen, U. Stervbo, P. Boudinot, S. M. Anderton, and S. Fillatreau. 2010. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol. Rev. 233: 146-161.
3. Reff, M. E., K. Carner, K. S. Chambers, P. C. Chinn, J. E. Leonard, R. Raab, R. A. Newman, N. Hanna, and D. R. Anderson. 1994. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83: 435-445. (Pubitemid 24030569)
4. Ahuja, A., S. M. Anderson, A. Khalil, and M. J. Shlomchik. 2008. Maintenance of the plasma cell pool is independent of memory B cells. Proc. Natl. Acad. Sci. USA 105: 4802-4807. (Pubitemid 351753827)
5. Cohen, S. B., P. Emery, M. W. Greenwald, M. Dougados, R. A. Furie, M. C. Genovese, E. C. Keystone, J. E. Loveless, G. R. Burmester, M. W. Cravets, et al. 2006. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebocontrolled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum. 54: 2793-2806. (Pubitemid 44497758)
6. Yanaba, K., Y. Hamaguchi, G. M. Venturi, D. A. Steeber, E. W. St Clair, and T. F. Tedder. 2007. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J. Immunol. 179: 1369-1380.
7. Hauser, S. L., E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar- Or, M. Panzara, N. Sarkar, S. Agarwal, et al. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688. (Pubitemid 351240747)
8. Matsushita, T., K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
9. Xiu, Y., C. P. Wong, J. D. Bouaziz, Y. Hamaguchi, Y. Wang, S. M. Pop, R. M. Tisch, and T. F. Tedder. 2008. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotypespecific differences in Fc γ R effector functions. J. Immunol. 180: 2863-2875.
10. Dass, S., E. M. Vital, and P. Emery. 2007. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum. 56: 2715-2718. (Pubitemid 47237290)
11. Ardelean, D. S., T. Gonska, S. Wires, E. Cutz, A. Griffiths, E. Harvey, S. M. Tse, and S. M. Benseler. 2010. Severe ulcerative colitis after rituximab therapy. Pediatrics 126: e243-e246.
12. Goetz, M., R. Atreya, M. Ghalibafian, P. R. Galle, and M. F. Neurath. 2007. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13: 1365-1368. (Pubitemid 350206846)
13. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278. (Pubitemid 27023727)
14. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950. (Pubitemid 35154008)
15. DiLillo, D. J., M. Horikawa, and T. F. Tedder. 2011. B-lymphocyte effector functions in health and disease. Immunol. Res. 49: 281-292.
16. Lampropoulou, V., K. Hoehlig, T. Roch, P. Neves, E. Calderón Gómez, C. H. Sweenie, Y. Hao, A. A. Freitas, U. Steinhoff, S. M. Anderton, and S. Fillatreau. 2008. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180: 4763-4773.
17. Carter, N. A., R. Vasconcellos, E. C. Rosser, C. Tulone, A. Muñoz-Suano, M. Kamanaka, M. R. Ehrenstein, R. A. Flavell, and C. Mauri. 2011. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186: 5569-5579.
18. Kang, Y., M. Melo, E. Deng, R. Tisch, M. El-Amine, and D. W. Scott. 1999. Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Proc. Natl. Acad. Sci. USA 96: 8609-8614. (Pubitemid 29354839)
19. Skupsky, J., Y. Su, T. C. Lei, and D. W. Scott. 2007. Tolerance induction by gene transfer to lymphocytes. Curr. Gene Ther. 7: 369-380. (Pubitemid 47595779)
20. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501. (Pubitemid 36278604)
21. Blair, P. A., K. A. Chavez-Rueda, J. G. Evans, M. J. Shlomchik, A. Eddaoudi, D. A. Isenberg, M. R. Ehrenstein, and C. Mauri. 2009. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182: 3492-3502.
22. Sun, J.-B., C. Czerkinsky, and J. Holmgren. 2010. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand. J. Immunol. 71: 1-11.
23. Sun, J.-B., C.-F. Flach, C. Czerkinsky, and J. Holmgren. 2008. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J. Immunol. 181: 8278-8287.
24. + regulatory T cells and for expansion of these cells. J. Immunol. 178: 2018-2027.
25. - cells to develop suppressive activity: the role of IL-2, TGF-b, and IL-10. J. Immunol. 172: 5213-5221.
26. Shevach, E. M., D. Q. Tran, T. S. Davidson, and J. Andersson. 2008. The critical contribution of TGF-b to the induction of Foxp3 expression and regulatory T cell function. Eur. J. Immunol. 38: 915-917.
27. Wegmann, K. W., C. R. Wagner, R. H. Whitham, and D. J. Hinrichs. 2008. Synthetic peptide dendrimers block the development and expression of experimental allergic encephalomyelitis. J. Immunol. 181: 3301-3309.
28. Fillatreau, S. 2011. Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunol. Rev. 240: 52-71.
29. Frommer, F., T. J. Heinen, F. T. Wunderlich, N. Yogev, T. Buch, A. Roers, E. Bettelli, W. Müller, S. M. Anderton, and A. Waisman. 2008. Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion. J. Immunol. 181: 5748-5759.
30. Wu, H. Y., A. Monsonego, and H. L. Weiner. 2006. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression. J. Autoimmun. 26: 116-126. (Pubitemid 43138881)
31. Gray, M., K. Miles, D. Salter, D. Gray, and J. Savill. 2007. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl. Acad. Sci. USA 104: 14080-14085. (Pubitemid 350003338)
32. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230. (Pubitemid 34211962)
33. Yanaba, K., A. Yoshizaki, Y. Asano, T. Kadono, T. F. Tedder, and S. Sato. 2011. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178: 735-743.
34. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1: 475-482.
35. + phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
36. Matsushita, T., M. Horikawa, Y. Iwata, and T. F. Tedder. 2010. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 185: 2240-2252.
37. hiB cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 40: 1682-1696.
38. Calderón-Gómez, E., V. Lampropoulou, P. Shen, P. Neves, T. Roch, U. Stervbo, S. Rutz, A. A. Kühl, F. L. Heppner, C. Loddenkemper, et al. 2011. Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. Eur. J. Immunol. 41: 1696-1708.
39. Klinker, M. W., and S. K. Lundy. 2011. Multiple mechanisms of immune suppression by B lymphocytes. Mol. Med. DOI: .
40. Minagawa, R., S. Okano, Y. Tomita, K. Kishihara, H. Yamada, K. Nomoto, M. Shimada, Y. Maehara, K. Sugimachi, Y. Yoshikai, and K. Nomoto. 2004. The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen. Transplantation 78: 799-806. (Pubitemid 39298521)
41. + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178: 3447-3456.
42. Sun, J. B., C. Czerkinsky, and J. Holmgren. 2007. Sublingual "oral tolerance"induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells. Scand. J. Immunol. 66: 278-286. (Pubitemid 47063201)
43. Singh, A., W. F. Carson, IV, E. R. Secor, Jr., L. A. Guernsey, R. A. Flavell, R. B. Clark, R. S. Thrall, and C. M. Schramm. 2008. Regulatory role of B cells in a murine model of allergic airway disease. J. Immunol. 180: 7318-7326.
44. + T cells. Nat. Immunol. 8: 1353-1362.
45. Gordy, C., S. Mishra, and W. Rodgers. 2004. Visualization of antigen presentation by actin-mediated targeting of glycolipid-enriched membrane domains to the immune synapse of B cell APCs. J. Immunol. 172: 2030-2038. (Pubitemid 38182348)
46. Yuasa, T., S. Kubo, T. Yoshino, A. Ujike, K. Matsumura, M. Ono, J. V. Ravetch, and T. Takai. 1999. Deletion of fcγ receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J. Exp. Med. 189: 187-194. (Pubitemid 29047038)